results from tirzepatide Raleigh, N.C Semaglutide Or Tirzepatide: Which Weight

Small, consistent data points guide safer, more sustainable outcomes

The SURMOUNT clinical trial program demonstrated weight loss results that shocked even the researchers running the studies, with participants on the highest dose losing an average of 22.5% of their body weight over 72 weeks

You will remain on this dose for four weeks, and then you will increase to the Phase 1 Maintenance Dose

When you are already in a substantial caloric deficit with reduced nutrient intake, your recovery capacity is compromised

Higher mg per mL (15 mg/mL) More concentrated than lower-strength options Requires less volume per dose Ideal for patients on higher mg protocols Learn how to administer safely in seconds

[1] Some compounders suggest adding B12 to tirzepatide formulations based on theoretical concerns about vitamin B12 absorption, though it's important to note that clinical evidence specifically linking tirzepatide to B12 deficiency is lacking